礼来涨4.25% 股价突破800美元大关

市场透视12-20 22:33

北京时间2024年12月20日22时33分，礼来（LLY.us）股票出现波动，股价大幅上涨4.25%。截至发稿，该股报789.75美元/股，成交量172.53万股，换手率0.19%，振幅3.08%。最近的财报数据显示，该股实现营业收入114.39亿美元，净利润9.70亿美元，每股收益1.08美元，毛利92.68亿美元，市盈率85.10倍。机构评级方面，在所有31家参与评级的机构中，77%的券商给予...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2492011444?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-20 22:33","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2492011444","market":"us","top_or_hot":-1,"title":"礼来涨4.25% 股价突破800美元大关","media":"市场透视","content":"<div>\n<p>北京时间2024年12月20日22时33分，礼来（LLY.us）股票出现波动，股价大幅上涨4.25%。截至发稿，该股报789.75美元/股，成交量172.53万股，换手率0.19%，振幅3.08%。最近的财报数据显示，该股实现营业收入114.39亿美元，净利润9.70亿美元，每股收益1.08美元，毛利92.68亿美元，市盈率85.10倍。机构评级方面，在所有31家参与评级的机构中，77%的券商给予...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223303a1fe24ac&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>礼来涨4.25% 股价突破800美元大关</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n礼来涨4.25% 股价突破800美元大关\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-20 22:33 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223303a1fe24ac&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月20日22时33分，礼来（LLY.us）股票出现波动，股价大幅上涨4.25%。截至发稿，该股报789.75美元/股，成交量172.53万股，换手率0.19%，振幅3.08%。最近的财报数据显示，该股实现营业收入114.39亿美元，净利润9.70亿美元，每股收益1.08美元，毛利92.68亿美元，市盈率85.10倍。机构评级方面，在所有31家参与评级的机构中，77%的券商给予...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223303a1fe24ac&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1551013425.SGD","symbol_name":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223303a1fe24ac&s=b","article_id":"2492011444","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223303a1fe24ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2492011444","pubTimestamp":1734705182,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月20日22时33分，礼来股票出现波动，股价大幅上涨4.25%。截至发稿，该股报789.75美元/股，成交量172.53万股，换手率0.19%，振幅3.08%。最近的财报数据显示，该股实现营业收入114.39亿美元，净利润9.70亿美元，每股收益1.08美元，毛利92.68亿美元，市盈率85.10倍。礼来股票所在的制药行业中，整体涨幅为1.57%。康希诺表示，截至目前，暂无国内疫苗厂商研发的组分百白破疫苗获批上市，公司的婴幼儿用DTcP定位即为进口替代。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","BK4534":"瑞士信贷持仓","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","SG9999014880.SGD":"大华全球优质成长基金Acc SGD","LU2237443895.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC","SG9999017495.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"B\" (SGD) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU1917777945.USD":"安联专题基金Cl AT Acc","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","SG9999018865.SGD":"United Global Quality Growth Fd Cl Dist SGD-H","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","LU2360106947.USD":"BGF NUTRITION \"A4\" (USD) INC","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","LU0385154629.USD":"贝莱德营养科学基金A2","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU0256863902.USD":"ALLIANZ US EQUITY \"AT\" (USD) ACC","LU0079474960.USD":"联博美国增长基金A","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LU2461242641.AUD":"WELLINGTON US QUALITY GROWTH \"A\" (AUDHDG) ACC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","LU0471298777.SGD":"Blackrock Nutrition A2 SGD-H","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","SGXZ81514606.USD":"大华环球创新基金A Acc USD","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","BK4581":"高盛持仓","LU1069344957.HKD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (HKD) INC","LU0058720904.USD":"联博国际健康护理基金A","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU2063271972.USD":"富兰克林创新领域基金","LU1868836591.USD":"CT (LUX) I AMERICAN \"1U\"(USD) ACC","LU2361044949.HKD":"WELLINGTON US QUALITY GROWTH \"A\" (HKD) ACC","SG9999015978.USD":"利安颠覆性创新基金A","LU0882574055.USD":"富达全球健康医疗A ACC","LLY":"礼来","SG9999018857.SGD":"United Global Quality Growth Fd Cl Acc SGD-H","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU0122379950.USD":"贝莱德世界健康科学A2","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","BK4599":"减肥药"},"translate_title":"Eli Lilly rises 4.25%, shares break through the $800 mark","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LLY":1},"content_text":"北京时间2024年12月20日22时33分，礼来（LLY.us）股票出现波动，股价大幅上涨4.25%。截至发稿，该股报789.75美元/股，成交量172.53万股，换手率0.19%，振幅3.08%。最近的财报数据显示，该股实现营业收入114.39亿美元，净利润9.70亿美元，每股收益1.08美元，毛利92.68亿美元，市盈率85.10倍。机构评级方面，在所有31家参与评级的机构中，77%的券商给予买入建议，19%的券商给予持有建议，4%的券商给予卖出建议。礼来股票所在的制药行业中，整体涨幅为1.57%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 (To Pur Com)、Intercure Ltd.、Talphera, Inc.涨幅较大，Painreform Ltd.、Quantum Biopharma Ltd.、苏轩堂较为活跃，换手率分别为77.33%、20.97%、7.64%，振幅较大的相关个股有Quantum Biopharma Ltd.、Painreform Ltd.、Talphera, Inc.，振幅分别为15.03%、11.74%、11.68%。礼来公司简介：礼来制药公司是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。礼来制药公司的主要产品包括治疗癌症的Verzenio;治疗心脏代谢疾病的 Mounjaro、Zepbound、Jardiance、Trulicity、Humalog 和 Humulin；以及治疗免疫学疾病的 Taltz 和 Olumiant。消息层面，截至22时33分，《健讯Daily｜四部门印发《职业病分类和目录》；信达生物与礼来制药深化肿瘤领域合作》资讯为影响礼来的重要信息。该信息摘要如下：12月16日，圣湘生物公告，公司产品猴痘病毒核酸检测试剂盒近日收到国家药品监督管理局颁发的《医疗器械注册证》圣湘生物此次获证，有助于提升其在传染病检测领域的竞争力。康希诺表示，截至目前，暂无国内疫苗厂商研发的组分百白破疫苗获批上市，公司的婴幼儿用DTcP定位即为进口替代。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492011444"}